These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1042 related articles for article (PubMed ID: 28619031)

  • 1. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
    Buse K; Tanaka S; Hawkes S
    Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-communicable disease governance in the era of the sustainable development goals: a qualitative analysis of food industry framing in WHO consultations.
    Lauber K; Ralston R; Mialon M; Carriedo A; Gilmore AB
    Global Health; 2020 Aug; 16(1):76. PubMed ID: 32847604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing NCDs: Challenges From Industry Market Promotion and Interferences.
    Tangcharoensathien V; Chandrasiri O; Kunpeuk W; Markchang K; Pangkariya N
    Int J Health Policy Manag; 2019 May; 8(5):256-260. PubMed ID: 31204441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline status of policy and legislation actions to address non communicable diseases crisis in the Pacific.
    Win Tin ST; Kubuabola I; Ravuvu A; Snowdon W; Durand AM; Vivili P; Passmore E
    BMC Public Health; 2020 May; 20(1):660. PubMed ID: 32398159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-communicable Diseases.
    Suzuki M; Webb D; Small R
    Int J Health Policy Manag; 2022 Jul; 11(7):1078-1089. PubMed ID: 33619925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Big food and the World Health Organization: a qualitative study of industry attempts to influence global-level non-communicable disease policy.
    Lauber K; Rutter H; Gilmore AB
    BMJ Glob Health; 2021 Jun; 6(6):. PubMed ID: 34117011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention.
    Lencucha R; Thow AM
    Int J Health Policy Manag; 2019 Sep; 8(9):514-520. PubMed ID: 31657174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. China's Efforts on Management, Surveillance, and Research of Noncommunicable Diseases: NCD Scorecard Project.
    Zhu XL; Luo JS; Zhang XC; Zhai Y; Wu J
    Ann Glob Health; 2017; 83(3-4):489-500. PubMed ID: 29221521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-Processed Profits: The Political Economy of Countering the Global Spread of Ultra-Processed Foods - A Synthesis Review on the Market and Political Practices of Transnational Food Corporations and Strategic Public Health Responses.
    Moodie R; Bennett E; Kwong EJL; Santos TM; Pratiwi L; Williams J; Baker P
    Int J Health Policy Manag; 2021 Dec; 10(12):968-982. PubMed ID: 34124866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrition related non-communicable diseases and sugar sweetened beverage policies: a landscape analysis in Zambia.
    Mukanu MM; Abdool Karim S; Hofman K; Erzse A; Thow AM
    Glob Health Action; 2021 Jan; 14(1):1872172. PubMed ID: 33876714
    [No Abstract]   [Full Text] [Related]  

  • 11. The
    Lloyd-Williams F; Masters R; Hyseni L; Denny ES; O'Flaherty M; Capewell S
    Int J Health Policy Manag; 2021 Oct; 10(10):638-646. PubMed ID: 32610821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries.
    Moodie R; Stuckler D; Monteiro C; Sheron N; Neal B; Thamarangsi T; Lincoln P; Casswell S;
    Lancet; 2013 Feb; 381(9867):670-9. PubMed ID: 23410611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.
    Jailobaeva K; Falconer J; Loffreda G; Arakelyan S; Witter S; Ager A
    Global Health; 2021 Jun; 17(1):68. PubMed ID: 34187499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-sectoral action in non-communicable disease prevention policy development in five African countries.
    Juma PA; Mapa-Tassou C; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Oluwasanu M; Mbanya JC; Nkhata MJ; Asiki G; Kyobutungi C
    BMC Public Health; 2018 Aug; 18(Suppl 1):953. PubMed ID: 30168391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender and non-communicable diseases in Mexico: a political mapping and stakeholder analysis.
    Orozco-Núñez E; Ojeda-Arroyo E; Cerecer-Ortiz N; Guerrero-López CM; Ramírez-Pérez BM; Heredia-Pi I; Allen-Leigh B; Feeny E; Serván-Mori E
    Health Res Policy Syst; 2024 Apr; 22(1):46. PubMed ID: 38605301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-of-government approaches to NCDs: the case of the Philippines Interagency Committee-Tobacco.
    Lencucha R; Drope J; Chavez JJ
    Health Policy Plan; 2015 Sep; 30(7):844-52. PubMed ID: 25096748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The state of diet-related NCD policies in Afghanistan, Bangladesh, Nepal, Pakistan, Tunisia and Vietnam: a comparative assessment that introduces a 'policy cube' approach.
    Buse K; Aftab W; Akhter S; Phuong LB; Chemli H; Dahal M; Feroz A; Hofiani S; Pradhan NA; Anwar I; Skhiri HA; El Ati J; Giang KB; Puri M; Noormal B; Rabbani F; Hawkes S
    Health Policy Plan; 2020 Jun; 35(5):503-521. PubMed ID: 32091080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Political Economy of Non-Communicable Disease (NCD) prevention and control in Lebanon: identifying challenges and opportunities for policy change and care provision reforms.
    Bou-Orm IR; Loffreda G; Diaconu K; Witter S; deVos P
    BMC Public Health; 2023 Dec; 23(1):2526. PubMed ID: 38110967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-communicable disease prevention policy process in five African countries.
    Juma PA; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Mapa-Tassou C; Oluwasanu M; Oladepo O; Abiona O; Nkhata MJ; Wisdom JP; Mbanya JC
    BMC Public Health; 2018 Aug; 18(Suppl 1):961. PubMed ID: 30168393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding Structure and Agency as Commercial Determinants of Health Comment on "How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention".
    Lee K; Crosbie E
    Int J Health Policy Manag; 2020 Jul; 9(7):315-318. PubMed ID: 32613804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.